Wang, Zhifei <br/><br/>
Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation.  [electronic resource] 

 -  Scientific reports  Jan 2016 
 - 19626 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep19626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Animals<br/>Brain Infarction--drug therapy<br/>Cell Death--drug effects<br/>Disease Models, Animal<br/>Fibroblast Growth Factors--genetics<br/>Gene Expression Regulation<br/>Glutamic Acid--metabolism<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Hydroxamic Acids--pharmacology<br/>Indoles--pharmacology<br/>Mitochondria--drug effects<br/>Neurites--metabolism<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Rats<br/>Recovery of Function--drug effects<br/>Signal Transduction--drug effects<br/>Tubulin--metabolism<br/>Up-Regulation--drug effects